| Bioactivity | Tofisopam, a 2,3-benzodiazepine compound, is an orally active anxiolytic agent[1]. |
| Invitro | Tofisopam administration at a dose of 50 mg/kg for seven days improves the impaired cognitive performance, enhances the attenuated synaptic transmission in the hippocampus, increases proliferation in subgranular zones, and improves the decrease in astrocytes in amnesic rats[1]. |
| Name | Tofisopam |
| CAS | 22345-47-7 |
| Formula | C22H26N2O4 |
| Molar Mass | 382.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Umut İrfan Üçel, et al. Antiamnesic effects of tofisopam against scopolamine-induced cognitive impairments in rats. Pharmacol Biochem Behav. 2020 Mar;190:172858. |